Patterns of sustained e-cigarette use in a sample of young adults.
Individual Clinical
Consumer Use
Youth Use & Appeal
Creamer (2019)
Biomarkers of Exposure among “Dual Users” of Tobacco Cigarettes and Electronic Cigarettes in Canada.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Czoli (2019)
a Longitudinal Study of Exposure to Tobacco-Related Toxicants and Subsequent Respiratory Symptoms among U.S. adults with Varying E-cigarette Use Status.
Individual Clinical
Respiratory Toxicity; Biomarkers
Relative Health Effects Of User; Biomarkers Of Exposure
Dai (2020)
Exposure to Toxicants associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Dai (2022)
Trends in Urinary Biomarkers of Exposure to Nicotine and Carcinogens among adult e-Cigarette Vapers vs Cigarette Smokers in the US, 2013-2019.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Dai (2022)
Pilot study to determine differences in breath odour between cigarette and e-cigarette consumers.
Individual Clinical
Safety
Adverse Effects
Dalrymple (2022)
Impact of vaping and smoking on maximum respiratory pressures and respiratory function.
Individual Clinical
Safety
Adverse Effects
Darabseh (2021)
Real-Time Characterization of E-Cigarettes Use: The 1 Million Puffs Study
Individual Clinical
User Topography
Dautzenberg (2015)
E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
de Lima (2023)
Effect of Electronic Cigarettes on the Gastrointestinal System.
Individual Clinical
Safety
Adverse Effects
Debnath (2022)